Old Web
English
Sign In
Acemap
>
authorDetail
>
Ld Köthe
Ld Köthe
Internal medicine
Endocrinology
Diabetes mellitus
Medicine
Glucagon-like peptide-1
6
Papers
196
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Quantification of the Contribution of GLP-1 to Mediating Insulinotropic Effects of DPP-4 Inhibition With Vildagliptin in Healthy Subjects and Patients With Type 2 Diabetes Using Exendin [9-39] as a GLP-1 Receptor Antagonist
2016
Diabetes
Michael A. Nauck
Joachim Kind
Ld Köthe
Jens J. Holst
Carolyn F. Deacon
Matthias Broschag
Yan-Ling He
Lise L. Kjems
James E. Foley
Show All
Source
Cite
Save
Citations (36)
Inhibition of DPP-4 with Vildagliptin Improved Insulin Secretion in Response to Oral as well as “Isoglycemic” Intravenous Glucose without Numerically Changing the Incretin Effect in Patients with Type 2 Diabetes
2011
The Journal of Clinical Endocrinology and Metabolism
Irfan Vardarli
Michael A. Nauck
Ld Köthe
Carolyn F. Deacon
Jens J. Holst
Anja Schweizer
James E. Foley
Show All
Source
Cite
Save
Citations (53)
GIP does not potentiate the antidiabetic effects of GLP-1 in hyperglycemic patients with type 2 diabetes.
2011
Diabetes
Nikolaos Mentis
Irfan Vardarli
Ld Köthe
Jens J. Holst
Carolyn F. Deacon
Michael J. Theodorakis
Juris J. Meier
Michael A. Nauck
Show All
Source
Cite
Save
Citations (107)
„Glucose-depedent Insulinotropic Polypeptide“ (GIP) verstärkt die antidiabetischen Wirkungen von "Glucagon-Like Peptide-1" (GLP-1) bei hyperglykämischen Patienten mit Typ 2-Diabetes mellitus nicht
2009
Diabetologie Und Stoffwechsel
N Mentis
Ld Köthe
Jens J. Holst
Carolyn F. Deacon
V Wan Sze Ng
Michael J. Theodorakis
Nawrodt B
K Rotenberger
Michael A. Nauck
Show All
Source
Cite
Save
Citations (0)
1